VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
1.490
-0.010 (-0.67%)
At close: Apr 28, 2026, 4:00 PM EDT
1.490
0.00 (0.00%)
Pre-market: Apr 29, 2026, 7:01 AM EDT
VivoSim Labs Revenue
VivoSim Labs had revenue of $26.00K in the quarter ending December 31, 2025, with 8.33% growth. This brings the company's revenue in the last twelve months to $142.00K, up 16.39% year-over-year. In the fiscal year ending March 31, 2025, VivoSim Labs had annual revenue of $144.00K with 32.11% growth.
Revenue (ttm)
$142.00K
Revenue Growth
+16.39%
P/S Ratio
30.37
Revenue / Employee
$10,143
Employees
14
Market Cap
4.31M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jaguar Health | 11.51M |
| 60 Degrees Pharmaceuticals | 1.41M |
| SciSparc | 1.31M |
| AIM ImmunoTech | 88.00K |
| Pulmatrix | 3.00K |
| Soligenix | 2.34K |
VIVS News
- 23 hours ago - VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing - GlobeNewsWire
- 27 days ago - VivoSim Announces Pricing of up to a $4 Million Public Offering - GlobeNewsWire
- 5 weeks ago - VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs - GlobeNewsWire
- 2 months ago - VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales - GlobeNewsWire
- 2 months ago - VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego - GlobeNewsWire
- 3 months ago - VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China - GlobeNewsWire
- 4 months ago - VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer - GlobeNewsWire
- 9 months ago - VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer - GlobeNewsWire